MEDICA: Undisputedly the world’s most important trade show and gathering place for the medical industry worldwide. Americans have long been a driving force behind both the quality and size of this event, on average featuring over 500 US-based companies occupying about 2 acres (or about 1½ US football fields!) of exhibit space at the Düsseldorf fairgrounds.
Over the past decade in particular, mobile, IoT and big data has emerged as perhaps the most revolutionizing dynamic in the medical industry marketplace, and the US med-tech industry not surprisingly continues to dominate the global landscape. Some industry reports suggest digital health market revenues here may surpass $150 billion within the next 5-7 years.
In tandem, FTR4H FUTURE FOR HEALTH is an international platform powered by MEDICA that has risen alongside to highlight wireless and digital technologies – showcasing and exploring how digital transformation is affecting and will continue to drive important developments in the healthcare industry.
And now for the first time, the USA Pavilion at MEDICA 2017 will also feature a FTR4H LAB showcasing innovators and visionaries in this field.
The first company to join the FTR4H LAB is Westlake, Ohio based Blue Spark Technologies, Inc. A pioneering developer of thin, flexible, printed power solutions, Blue Spark Technologies’ latest innovation, TempTraq®, is the only Bluetooth® wearable continuous temperature monitor in the form of a soft patch that can continuously and comfortably monitor body temperature for up to 72 hours, sending real-time temperature data to a Hospital’s Nurse Monitoring Stations, EHR, and Smart Devices. With TempTraq’s new TempTraq Connect HIPAA-complaint Cloud, it can also be used remotely and enable a hospital to monitor patients at home in real time.
TempTraq has been tested in the most demanding environments at leading hospitals including Cleveland Clinic, University Hospital’s Seidman Cancer Center and Akron Children’s Hospital and has been clinically proven to detect fever 30 – 180 minutes earlier than a 4 Hour SOC in trials with Bone Marrow Transplant Patients (Abstracts available upon request). TempTraq is an FDA cleared Class 2 Medical Device and by November and MEDICA, the device will be CE approved and available for both Consumer and Clinical markets in Europe.
For more information about TempTraq®, plan to visit them at MEDICA 2017 – hall 16 / stand C20-6 or contact Blue Spark Technologies / VP of Sales, Mr. John Baragar email@example.com
For more information about joining the FTR4H LAB in the USA Pavilion at MEDICA 2017, contact Messe Düsseldorf North America / Sr. Business Development Manager, Mr. Ryan Klemm firstname.lastname@example.org
8 start-ups are present at our FTR4H lounge at MEDICAL FAIR INDIA in New Delhi. They are:
Focus 1: Children’s health
iNICU !!!WINNER OF THE #FTR4H INDIA AWARD !!!!!
iNICU stands for ‘Integrated Neonatal Intensive Care Unit’. The solution is leveraging IOT and Big Data,connecting generated source data from various devices.
iNICU is a one stop workflow solution to assimilate and disseminate neonate information. The application is designed to help improve management of all responsibilities of various professionals (Nurse, Resident Doctor, Senior Doctor, Pediatrician and Administrator) involved in the care of a baby.
A solution for an important but hitherto ignored area – Student Wellness. It helps monitor, track and control children’s wellness in school, making it easier for parents and teachers recognize struggles of specific students. This makes it easier for the carers to find ways to help students cope with their problems easier and make most of their potentials.
Focus 2: data optimization, presentation, utilization
Empowering transformation along enterprises in various verticals, mainly in the field of Education & Learning solutions. A mixed approach with Open Source & proprietary offerings enable institutions achieve higher levels of transformation, in much affordable way.
Abda Digital (a Tech Vedika Pvt. Ltd. spin off) has been establish with vision to develop innovative products specifically for the mobile and digital space. The inception of Abda in November 2015 marked commitment to focus on product ideas that could help organizations communicate with their target audiences in the best way using less time.
Focus 3: Women’s health
Doc n me
Management software for obstetricians and gynecologists is offering End-to-End Solution to all ObGyn Practice Management Challenges. This solutions offers a new way of communication between the expecting mother, obstetricians and gynecologists. Between visits in the doctors office, the mother can ask questions with the help of a platform.
Focus 4: Cardiology, trackers, sensors
Cardiotrack brings portability to healthcare diagnostics. Cardiotrack health sensors provide clinical grade reading for 12-lead ECG, SpO2 and blood pressure. Robust design makes Cardiotrack an ideal solution for home healthcare, tele-health, doctor’s clinic, nursing home or primary healthcare.
This solution is altering the delivery of critical life saving health care monitoring during emergency and preventive diagnostic capabilities. This is done at a much lower price-performance points, thanks to innovative synthesis of digital signal processing, image processing, biomedical components, algorithms, wireless and communication technologies. The first sets of solutions are in the realm of wireless remote patient monitoring.
Track my beat
TrackMyBeat is a healthcare technology and analytics company, offering a complete health and wellness management system. It focuses on the prevention of lifestyle diseases. The subscriber can proactively manage his or her health through automated alerts. The product also highlights the efficacy of various interventions and activities in improving the user’s well-being.
Wearables and measurements. Which Point of Care devices are just gadgets and which ones bring actual better outcomes for patients? Here’s what’s wrong with wearables.
1. Questionable data gathering
When used for prevention, it has become clear by now, that a person gets tired of using a wearable or a health app in only a few months. It is important to note that this holds true mostly for relatively healthy people, not patients with serious illnesses.
2. We are measuring what we can, not what we should
British researcher Prof. Dr. Anthony Turner, Head of The Biosensors and Bioelectronics Centre at Linköping University Sweden: “we haven’t yet made the sensors we really need, we are using the sensors that we happen to have.” That is why in recent years investors have been more interested in other sensors: ingestibles, implantables, etc..
We are entering an era of sensors for complex chemical reactions and molecular recognition in the body. “This requires more regulation and caution in testing and development,” says Prof. Dr. Turner. However, we can expect more significant improvements and outcomes.
3. Questionable measurements
Apart from data being questionable due to inconsistent data gathering by the user, another issue is data reliability. If you wear your phone with a tracker and two tracking wearables for activity measurements, you are bound to get different results. Similar is true for home Point of Care devices. Are they then useful or harmful?
If you will ask laboratory technicians, they will tell you that Point of Care devices are far from laboratory accurate. But in which cases is that relevant? As Prof. Dr. Turner says, “from a laboratory perspective and for research purposes you always look for the best. However, Point of Care devices for patients just need to be good enough for managing conditions and early warnings. Personal devices for diabetes are not as accurate as clinical laboratory, but it doesn’t matter – they are good enough for management decision.”
You can listen the whole conversation with prof. dr. Anthony Turner here.
So what can we conclude out of all this? Wearables are simply a step in the evolution of health technology. Sensors are still promising us all a bright future. They bring:
More and more of them are embedded in the environment. Measuring is becoming seamless, taking away the issue of consistency with gathering data.
Biosensors have had a very long and successful history of miniaturization. “It took 20 years for that to happen for wearable blood glucose monitors, while glucose meters evolved from a huge instrument of 40,000 dollars to a device which today costs 7-17 dollars,” illustrates Prof. Dr Turner. For inventors, the biggest issue is, what kind of business model will work. But the final judgement from a financial perspective is clear: massive savings could be achieved.
Want to know more? Tune into the sixth episode of Medicine Today on Digital Health podcast. You can find, listen, subscribe, rate, follow, share the podcast in Soundcloud or in iTunes.